SMR NUSCALE POWER Corp Insider Trading

NuScale director Fluor Corp sells 12,936,472 shares (48.9% of holdings) for $150.4M; stock down -37.4% in 90 days post-sale.

A director affiliated with Fluor Corp sold 12,936,472 shares of NUSCALE POWER Corp (SMR) at $11.63 on 2026-04-15, reducing holdings from 26,436,472 shares to 13,500,000 shares. The company is unprofitable (net income $-273,319,000.00 in the latest full fiscal year) with declining revenue (annual revenue growth -15.0%), while the transaction represented a substantial liquidation of nearly half the insider's position. The insider's cross-ticker track record shows strong timing: 20 prior sells averaged 90-day returns of -59.0%, with a 100.00% well-timed rate at the 90-day mark. At the same ticker (SMR), 2 of 2 prior sells with measurable 90-day outcomes were similarly well-timed, with returns of -51.1% and -50.4%. SMR has since fallen -37.4% over 90 days, consistent with this insider's historical pattern of selling before declines.

NuScale Power (SMR) director sold 13.50M shares at $12.07 on 2026-04-09 ($162.9M); -33.8% of holdings.

A director at NuScale Power divested 13,500,000 shares at $12.07, representing a 33.8% reduction in holdings to 26,436,472 shares remaining. This sale occurred at a price substantially above the current market level of $9.58, which is now 82.1% below the 52-week high of $53.43 and down 18.8% in 30 days and 50.2% in 90 days. The insider's cross-ticker track record shows 20 prior sells with a 100.00% well-timed rate at the 90-day mark, and at this specific ticker, 3 of 3 prior sells showed negative 90-day returns (ranging from -51.1% to -52.5%), establishing a pattern of selling ahead of declines. Against this backdrop, the company is unprofitable (net income of -$273.3M in the latest quarter), reporting declining revenue growth of -15.0% year-over-year, with minimal quarterly revenue of $8.2M. The timing and scale of this divestiture, combined with the company's deteriorating fundamentals and the insider's historical pattern at this ticker, warrants investor scrutiny of the underlying business trajectory.

NuScale COO Carl Fisher sells 49,277 shares at $12.64 as stock falls 78.2% from 52-week high of $53.43.

Carl Fisher, Chief Operating Officer of NuScale Power Corp, executed 2 separate sales totaling 49,277 shares (49.3K shares) for $622,861.28 ($622.9K) at $12.64 per share on 2026-03-04, reducing his holdings by 35.2% to 90,864 shares (90.9K shares). The transaction occurred as SMR's stock trades at $11.67, down 78.2% from its 52-week high of $53.43 and down 28.0% over the prior 30 days. The company is unprofitable (net income $-273,319,000.00 for the latest full fiscal year) with declining revenue (annual growth -15.0%). Fisher's prior sale at this ticker on 2025-08-05 was well-timed: the stock fell 8.0% over the subsequent 90 days. In his cross-ticker track record, his 1 prior open-market sale was well-timed with an average 90-day return of -8.0%, reflecting a 100.00% well-timed rate. The current sale at elevated net negative price action follows a pattern consistent with prior exits before further deterioration.

NuScale CEO sold 82,667 shares (-41.4% of holdings) at $12.22; stock now -76.6% from 52-week high of $53.43

Hopkins sold 82,667 shares on 2026-03-03 at $12.22, reducing his stake from 199,685 to 117,018 shares and raising $1,010,190.74. The sale occurs amid severe price deterioration: the stock is -28.3% over 30 days and -37.8% over 90 days, trading at $12.53 versus a 52-week high of $53.43 (-76.6%). NuScale's fundamentals underscore the backdrop: latest quarterly revenue is $8.2M with annual revenue declining -15.0%, and the company posted a net loss of $273.3M, remaining unprofitable on a full-year basis. His prior sales at SMR show mixed timing outcomes (1 of 5 prior trades well-timed at the 90-day mark), including a -8.1% 30-day result on a similar 2025-03-03 sale. The magnitude of this reduction—41.4% of holdings—alongside accelerating stock weakness and deteriorating financial performance merits investor attention.

Director of Fluor sold 463.7K SMR shares at $13.15 on 2026-02-26; stock -75.6% from 52-week high, -31.0% over 90 days.

A Fluor Corp director sold 463,747 shares of NuScale Power (SMR) at $13.15 per share on 2026-02-26, reducing holdings by -1.1% to 39,936,472 shares remaining. The stock has declined sharply: -75.6% from its 52-week high of $53.43, -31.0% over the past 90 days, and -25.3% over the past 30 days. The company faces significant headwinds—revenue contracted -15.0% year-over-year, and NuScale is unprofitable with a net loss of $-273,319,000.00 in the most recent full fiscal year against quarterly revenue of only $8,242,000.00. The insider's timing at SMR has been consistently well-timed: 4 of 4 prior measurable sales at this ticker (October 2025) all showed negative 90-day returns (-17.8% to -56.0%), meaning the insider sold before subsequent declines. This sale follows another SMR sale just 13 days prior (2026-02-13), part of a pattern of continuous selling into a deteriorating stock and operational environment.

Director sold 71,000,000 SMR shares at $19.05 on 2026-02-13, reducing holdings 63.7%; stock now $14.27, down 73.3% from 52-week high.

A Fluor Corp director sold 71,000,000 shares (71.00M shares) of NuScale Power at $19.05 on 2026-02-13 for $1,352,535,800.00, cutting holdings from 111,400,219 shares to 40,400,219 shares (-63.7% net change). The transaction occurred at a price that has since declined substantially: the stock now trades at $14.27, representing a 73.3% loss from the 52-week high of $53.43 and a 29.3% decline over the prior 30 days. Notably, the insider's cross-ticker sell track record shows a 100.00% well-timed rate across 20 prior sales (average 90-day return -59.3%), and at this same ticker, all 5 prior sells were well-timed at the 90-day mark, with 90-day returns ranging from -50.4% to -56.5%. The company remains unprofitable (net income $-273,319,000.00 for the latest period) despite strong revenue growth of 62.4% year-over-year, underscoring fundamental cash burn concerns alongside the insider's substantial capital reduction.

CFO Hamady Robert Ramsey sold 40,000 SMR shares at $22.17; stock now $20.32, down -62.0% from 52-week high of $53.43

Hamady Robert Ramsey, CFO of NuScale Power, sold 40,000 shares (46.4% of his pre-transaction holdings) at $22.17 on 2025-12-08 for $886,800.00. The transaction occurred as the stock has declined sharply: SMR is currently at $20.32, down -62.0% from its 52-week high of $53.43 and -28.5% over the past 30 days. His prior trades at SMR show a mixed record: 2 of 4 prior sales were well-timed at the 90-day mark (stock subsequently declined), while his cross-ticker track record shows 50.00% well-timed sell rate with an average 90-day return of -12.7%. NuScale remains unprofitable (full-year net income was negative), though revenue grew 62.4% year-over-year, generating $8.2M in latest quarter revenue. The CFO's substantial position reduction during a period of sharp stock depreciation and persistent losses warrants investor attention to whether this reflects operational confidence or concerns about the company's near-term trajectory.

NuScale director liquidates entire 908,761-share position for $36.9M across 7 sales on Oct 7–8; stock -21.4% from 52-week high.

A FLUOR CORP director filed 7 separate sales totaling 908,761 shares for $36,868,176.10 on October 7–8, 2025, liquidating his entire position at a blended average price of $40.57. The timing coincides with the stock trading near its 52-week high of $51.67 (currently -21.4% below that peak, at $40.61). This complete exit—from 908.8K shares to 0 shares—represents a material change in insider ownership stakes. The company remains unprofitable (net income of $-17,641,000 in the latest quarter; full-year net income was negative) despite strong revenue growth of 62.4% year-over-year, and current market cap stands at $9,614,618,438.28. Prior same-ticker trades by this director (5 sales on October 3 and October 6) occurred just days before this larger liquidation, suggesting a multi-day exit pattern.

Fluor director sold 2,515,517 shares of NuScale Power for $101.3M over three days, reducing stake by 73.5%

A Fluor Corp director executed 9 separate sales totaling 2,515,517 shares for $101,292,662.36 across October 2–6, 2025, reducing holdings from 3,424,278 to 908,761 shares (a -73.5% reduction). Transactions ranged from $37.45 to $43.62 per share with a blended average of $40.27, occurring as the stock traded near recent highs (current price $41.94 is -18.8% from the 52-week peak of $51.67). The timing is noteworthy: NuScale is unprofitable with net income of -$17,641,000 in its latest quarter and full-year losses, despite revenue growth of +62.4% year-over-year and a $9.9B market cap. The director's prior 5 trades at NuScale are all recent sells (2025-09-29 through 2025-10-01), establishing a consistent pattern of liquidation over a compressed window. This aggressive reduction of a substantial ownership stake warrants investor scrutiny of capital allocation priorities and conviction levels at an early-stage nuclear technology company still in the path to profitability.

CTO Reyes sold 66,000 shares across 2 tranches in July and October 2025 for $2.4M at avg $36.56; stock now $40.12

Reyes Jose N Jr executed two separate sales totaling 66,000 shares ($2.4M) at an average price of $36.56, reducing his holdings by 23.0% to 220,630 shares post-transaction. The sales occurred on 2025-07-01 (33,000 shares at $36.62) and 2025-10-01 (33,000 shares at $36.50), bracketing a multi-month period. The current stock price of $40.12 sits 9.8% above the blended average sale price, suggesting the CTO sold below the subsequent price trajectory, though his cross-ticker track record shows a 100.00% well-timed rate across 2 prior sells (average 90-day return of -5.6%), indicating a pattern of selling ahead of declines. At NuScale Power—a company generating $8.1M in quarterly revenue against a net loss of $17.6M and a $9.5B market cap—the concentrated sale by a C-suite technologist during a period of unprofitability may signal differing assessments of near-term execution risk versus longer-term thesis.